Table 2 Antibiotic susceptibility pattern of the tested clinical isolates
Isolates | Isolate1 | Isolate 2 | Isolate 3 | Isolate 4 | Isolate 5 | Isolate 6 | Isolate 7 | Isolate 8 | Isolate 9 | Isolate 10 |
|---|---|---|---|---|---|---|---|---|---|---|
Antibiotics and their groups | ||||||||||
Benzylpenicillin (β-lactams) | R | R | R | R | R | R | R | R | R | R |
Oxacillin (β-lactams) | R | R | R | R | S | R | R | R | R | S |
Gentamicin (aminoglycoside) | R | R | S | R | S | R | S | S | S | S |
Ciprofloxacin (quinolones) | R | R | S | R | R | R | R | S | S | S |
Moxifloxacin (quinolones) | R | R | S | I | R | I | R | S | S | S |
Erythromycin (macrolides) | R | R | R | R | R | R | R | R | S | S |
Clindamycin (lincosamides) | R | R | R | R | S | R | R | R | R | S |
Teicoplanin (glycopeptide) | R | R | R | R | S | R | R | S | S | S |
Vancomycin (glycopeptide) | R | R | R | R | R | R | R | I | S | R |
Tetracycline (Tetracyclines) | R | S | R | R | S | R | R | R | S | S |
Tigecycline | R | S | S | S | S | S | S | S | S | S |
Fusidic acid | R | R | R | R | R | R | R | R | R | R |
Rifampicin (ansamycins) | R | S | S | R | S | R | R | S | S | S |
Trimethoprim/ Sulfamethoxazole (sulphonamides) | S | S | S | R | R | R | R | R | S | S |